These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9296473)

  • 21. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
    Popma JJ; Suk J
    Am J Cardiol; 2001 Oct; 88(8A):25K-29K. PubMed ID: 11694216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.
    Jernberg T; Abrahamsson P; Lindahl B; Johanson P; Wallentin L; Dellborg M
    Eur Heart J; 2002 Jul; 23(14):1093-101. PubMed ID: 12090747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
    Sätre H; Holmvang L; Wagner GS; Lindahl B; Wallentin L
    Eur Heart J; 1999 May; 20(9):645-52. PubMed ID: 10208784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New frontiers in the management of unstable coronary artery disease.
    Turpie AG
    Am J Cardiol; 1997 Sep; 80(5A):21E-24E. PubMed ID: 9296465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute management--how should we intervene?
    Kontny F
    Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I8-12. PubMed ID: 10680038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.
    Lindahl B; Venge P; Wallentin L
    J Am Coll Cardiol; 1997 Jan; 29(1):43-8. PubMed ID: 8996293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of unstable angina: lessons from the TACTICS-TIMI 18 trial.
    Manoharan G; Adgey AA
    Am J Cardiovasc Drugs; 2002; 2(4):237-43. PubMed ID: 14727969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpreting new treatment guidelines for non-ST-segment elevation acute coronary syndromes.
    Boden WE
    Am J Cardiol; 2001 Oct; 88(8A):19K-24K. PubMed ID: 11694215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization.
    Husted SE; Wallentin L; Lagerqvist B; Kontny F; Ståhle E; Swahn E
    Eur Heart J; 2002 Aug; 23(15):1213-8. PubMed ID: 12127923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS study.
    Wallentin L; Dellborg DM; Lindahl B; Nilsson T; Pehrsson K; Swahn E
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I12-4. PubMed ID: 11286309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dalteparin for acute coronary syndromes.
    O'Loughlin DC
    Heart Dis; 1999; 1(5):329-36. PubMed ID: 11720639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators.
    Lagerqvist B; Säfström K; Ståhle E; Wallentin L; Swahn E;
    J Am Coll Cardiol; 2001 Jul; 38(1):41-8. PubMed ID: 11451294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of low molecular weight heparin to predict clinical outcome in patients with unstable angina that had undergone percutaneous coronary intervention.
    Hong YJ; Jeong MH; Lee SH; Park OY; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Park JC; Suh SP; Ahn BH; Kim SH; Kang JC
    Korean J Intern Med; 2003 Sep; 18(3):167-73. PubMed ID: 14619386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulants in acute coronary syndromes.
    Turpie AG
    Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.
    Lagerqvist B; Husted S; Kontny F; Ståhle E; Swahn E; Wallentin L;
    Lancet; 2006 Sep; 368(9540):998-1004. PubMed ID: 16980115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
    Wallentin L; Bergstrand L; Dellborg M; Fellenius C; Granger CB; Lindahl B; Lins LE; Nilsson T; Pehrsson K; Siegbahn A; Swahn E
    Eur Heart J; 2003 May; 24(10):897-908. PubMed ID: 12714021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting treatment for optimal outcome.
    Husted SE
    Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I18-22. PubMed ID: 10680040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
    Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
    N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial.
    Janzon M; Levin LA; Swahn E;
    Heart; 2003 Mar; 89(3):287-92. PubMed ID: 12591833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.